Omega 3 Supplements Market To Reach $16.2 Billion By 2033

October 2026 | Report Format: Electronic (PDF)

Omega 3 Supplements Market Growth & Trends

The global omega 3 supplements market size is expected to reach USD 16.2 billion by 2033, registering a CAGR of 8.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. The demand for omega-3 supplements is projected to be driven by the growing adoption of the product to fulfill the daily nutritional requirements and maintain optimum health of organs by the geriatric population in developed economies, such as the U.S., Canada, the U.K., and France.

Furthermore, the outbreak of COVID-19 from the beginning of 2020 led to increased consumer awareness regarding the significance of immunity and immunity-boosting products, which is expected to fuel the demand for various omega fatty acids products. Increasing incorporation of products in gummies form with novel flavor is expected to increase product penetration among children in the coming years.

Docosahexaenoic acid (DHA) is an omega-3 fatty acid comprising over 93.0% of omega-3 fats in the retina and 97.0% in the human brain. Rising demand for DHA supplements for pregnant ladies owing to lack of adequate DHA in the diet is expected to drive the market. Additionally, increasing demand for omega-3 DHA-rich supplements from non-lactating mothers is expected to propel the product demand over the forecast period.

Rising chronic diseases such as strokes, arthritis, coronary heart diseases, and cancer are expected to propel the demand for omega 3 supplements over the upcoming years. According to the World Health Organization (WHO), over 14 million people between the ages of 30 and 70 die every year due to distinguished chronic diseases. Rising government support to provide consumers with low-cost preventive drugs is projected to propel the demand for omega 3 supplements over the forecast period.

key Request a free sample copy or view report summary: Omega 3 Supplements Market Report

Omega 3 Supplements Market Report Highlights

Fish oil accounted for a revenue share of 61.1% in 2025. Fish oil is widely recognized as one of the richest sources of EPA and DHA, the two most beneficial omega-3 fatty acids linked to numerous health benefits, including improved cardiovascular health, cognitive function, and anti-inflammatory properties.
Soft gels form accounted for a revenue share of 40.1% in 2025. Factors such as ease of swallowing and taste masking make soft gels more appealing to consumers than tablets or capsules.
Cardiovascular health accounted for a revenue share of 36.4% in 2025. Rising consumer interest in maintaining cardiovascular health is encouraging supplement manufacturers to introduce formulations that combine omega-3 fatty acids with clearly defined nutritional benefits.
Adults accounted for a revenue share of 42.1% in 2025. The adult population ranges from 31 to 50 years old. These are mainly working populations with significant purchasing power, often experiencing chronic illnesses due to their demanding lifestyles.
OTC account for the largest revenue share of 74.5% in 2025. The convenience and accessibility of OTC omega-3 supplements have driven their popularity, as more individuals seek to manage their health independently.
North America holds the largest revenue share of 36.7% for the omega 3 supplements industry supported by consumer interest in preventive healthcare, cardiovascular wellness, healthy ageing, and nutritional products that complement daily dietary routines.

Omega 3 Supplements Market Segmentation

Grand View Research has segmented the global omega 3 supplements market on the basis of source, form, functionality, end-user, distribution channel, region:

Source Outlook (Revenue, USD Million, 2021 - 2033)